Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 214

1.

Blood pressure-related electrocardiographic findings in healthy young individuals.

Hassing GJ, van der Wall HEC, van Westen GJP, Kemme MJB, Adiyaman A, Elvan A, Burggraaf J, Gal P.

Blood Press. 2019 Nov 12:1-10. doi: 10.1080/08037051.2019.1673149. [Epub ahead of print]

PMID:
31711320
2.

Prevalent levels of RSV serum neutralizing antibodies in healthy adults outside the RSV-season.

van der Plas JL, Verdijk P, van Brummelen EMJ, Jeeninga RE, Roestenberg M, Burggraaf J, Kamerling IMC.

Hum Vaccin Immunother. 2019 Nov 1. doi: 10.1080/21645515.2019.1688040. [Epub ahead of print]

PMID:
31674870
3.

The simplified oral flucloxacillin absorption test: an accurate method to identify patients with inadequate oral flucloxacillin absorption.

Dijkmans AC, Kweekel DM, Balmforth C, van Esdonk MJ, van Dissel JT, Burggraaf J, Kamerling IMC.

Neth J Med. 2019 Sep;77(7):255-260.

4.

Immunomonitoring of Tacrolimus in Healthy Volunteers: The First Step from PK- to PD-Based Therapeutic Drug Monitoring?

In 't Veld AE, Grievink HW, Saghari M, Stuurman FE, de Kam ML, de Vries APJ, de Winter BCM, Burggraaf J, Cohen AF, Moerland M.

Int J Mol Sci. 2019 Sep 23;20(19). pii: E4710. doi: 10.3390/ijms20194710.

5.

The Oral Pheneticillin Absorption Test: An Accurate Method to Identify Patients with Inadequate Oral Pheneticillin Absorption.

Dijkmans AC, Kweekel DM, van Dissel JT, van Esdonk MJ, Kamerling IMC, Burggraaf J.

Antibiotics (Basel). 2019 Aug 15;8(3). pii: E119. doi: 10.3390/antibiotics8030119.

6.

No effect of topical digoxin and furosemide gel for patients with external anogenital warts.

Rijsbergen M, Rijneveld R, Todd M, Pagan L, Feiss G, de Koning MNC, van Alewijk DCJG, Klaassen ES, Burggraaf J, Rissmann R, van Poelgeest MIE.

J Eur Acad Dermatol Venereol. 2019 Aug 20. doi: 10.1111/jdv.15894. [Epub ahead of print] No abstract available.

PMID:
31430405
7.

Mobile e-diary application facilitates the monitoring of patient-reported outcomes and a high treatment adherence for clinical trials in dermatology.

Rijsbergen M, Niemeyer-van der Kolk T, Rijneveld R, Pinckaers JHFM, Meshcheriakov I, Bouwes Bavinck JN, van Doorn MBA, Hogendoorn G, Feiss G, Cohen AF, Burggraaf J, van Poelgeest MIE, Rissmann R.

J Eur Acad Dermatol Venereol. 2019 Aug 16. doi: 10.1111/jdv.15872. [Epub ahead of print]

PMID:
31419338
8.

A zwitterionic near-infrared fluorophore for real-time ureter identification during laparoscopic abdominopelvic surgery.

de Valk KS, Handgraaf HJ, Deken MM, Sibinga Mulder BG, Valentijn AR, Terwisscha van Scheltinga AG, Kuil J, van Esdonk MJ, Vuijk J, Bevers RF, Peeters KC, Holman FA, Frangioni JV, Burggraaf J, Vahrmeijer AL.

Nat Commun. 2019 Jul 16;10(1):3118. doi: 10.1038/s41467-019-11014-1.

9.

The Pharmacodynamic Effects of a Dopamine-Somatostatin Chimera Agonist on the Cardiovascular System.

van Esdonk MJ, Stevens J, Stuurman FE, de Boon WMI, Dehez M, van der Graaf PH, Burggraaf J.

J Cardiovasc Pharmacol. 2019 Aug;74(2):128-136. doi: 10.1097/FJC.0000000000000695.

PMID:
31306369
10.

Sensitivity and specificity of detection methods for erythropoietin doping in cyclists.

Heuberger JAAC, van Eenoo P, Rotmans JI, Gal P, Stuurman FE, Post TE, Daniels JMA, Ram H, de Hon O, Burggraaf J, Cohen AF.

Drug Test Anal. 2019 Sep;11(9):1290-1301. doi: 10.1002/dta.2665. Epub 2019 Jul 17.

11.

Effect of Food on the Pharmacokinetics of 2 Formulations of DRL-17822, a Novel Selective Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy Males.

Kruithof AC, Kumar R, Stevens J, de Kam ML, Gautam A, Alikunju S, Padhi BK, Kulkarni S, Raghuvanshi RS, Gandhi R, Burggraaf J, Kamerling IMC.

Clin Pharmacol Drug Dev. 2019 Nov;8(8):1042-1052. doi: 10.1002/cpdd.707. Epub 2019 Jun 10.

PMID:
31183985
12.

Colistin methanesulfonate infusion solutions are stable over time and suitable for home administration.

Post TE, Kamerling IMC, van Rossen RCJM, Burggraaf J, Stevens J, Dijkmans AC, Heijerman HGM, Touw DJ, van Velzen AJ, Wilms EB.

Eur J Hosp Pharm. 2018 Nov;25(6):337-339. doi: 10.1136/ejhpharm-2016-001128. Epub 2017 Mar 18.

13.

Body mass index related electrocardiographic findings in healthy young individuals with a normal body mass index.

Hassing GJ, van der Wall HEC, van Westen GJP, Kemme MJB, Adiyaman A, Elvan A, Burggraaf J, Gal P.

Neth Heart J. 2019 Oct;27(10):506-512. doi: 10.1007/s12471-019-1282-x.

14.

Whole blood assay as a model for in vitro evaluation of inflammasome activation and subsequent caspase-mediated interleukin-1 beta release.

Tran TAT, Grievink HW, Lipinska K, Kluft C, Burggraaf J, Moerland M, Tasev D, Malone KE.

PLoS One. 2019 Apr 8;14(4):e0214999. doi: 10.1371/journal.pone.0214999. eCollection 2019.

15.

Effect of short-term fasting on electrocardiographic parameters.

van der Stuijt W, Gal P, Kemme MJB, Burggraaf J.

Ann Noninvasive Electrocardiol. 2019 Sep;24(5):e12643. doi: 10.1111/anec.12643. Epub 2019 Apr 1.

PMID:
30938028
16.

Adverse immunostimulation caused by impurities: The dark side of biopharmaceuticals.

Reijers JAA, Malone KE, Bajramovic JJ, Verbeek R, Burggraaf J, Moerland M.

Br J Clin Pharmacol. 2019 Jul;85(7):1418-1426. doi: 10.1111/bcp.13938. Epub 2019 May 29. Review. Erratum in: Br J Clin Pharmacol. 2019 Sep;85(9):2182.

17.

Fluorescence-guided tumor detection with a novel anti-EpCAM targeted antibody fragment: Preclinical validation.

Boogerd LSF, Boonstra MC, Prevoo HAJM, Handgraaf HJM, Kuppen PJK, van de Velde CJH, Fish A, Cordfunke RA, Valentijn ARPM, Terwisscha van Scheltinga AG, MacDonald GC, Cizeau J, Premsukh A, Vinkenburg van Slooten ML, Burggraaf J, Sier CFM, Vahrmeijer AL.

Surg Oncol. 2019 Mar;28:1-8. doi: 10.1016/j.suronc.2018.10.004. Epub 2018 Oct 23.

PMID:
30851880
18.

Number of ECG Replicates and QT Correction Formula Influences the Estimated QT Prolonging Effect of a Drug.

van der Wall HEC, Gal P, Kemme MJB, van Westen GJP, Burggraaf J.

J Cardiovasc Pharmacol. 2019 Apr;73(4):257-264. doi: 10.1097/FJC.0000000000000657.

PMID:
30762613
19.

Stereophotogrammetric three-dimensional photography is an accurate and precise planimetric method for the clinical visualization and quantification of human papilloma virus-induced skin lesions.

Rijsbergen M, Pagan L, Niemeyer-van der Kolk T, Rijneveld R, Hogendoorn G, Lemoine C, Meija Miranda Y, Feiss G, Bouwes Bavink JN, Burggraaf J, van Poelgeest MIE, Rissmann R.

J Eur Acad Dermatol Venereol. 2019 Aug;33(8):1506-1512. doi: 10.1111/jdv.15474. Epub 2019 Mar 12.

20.

Under-representation of elderly in clinical trials: An analysis of the initial approval documents in the Food and Drug Administration database.

Ruiter R, Burggraaf J, Rissmann R.

Br J Clin Pharmacol. 2019 Apr;85(4):838-844. doi: 10.1111/bcp.13876. Epub 2019 Feb 23.

21.

Recombinant human erythropoietin does not affect several microvascular parameters in well-trained cyclists.

Birkhoff WAJ, Heuberger JAAC, Post TE, Gal P, Stuurman FE, Burggraaf J, Cohen AF.

Physiol Rep. 2018 Dec;6(24):e13924. doi: 10.14814/phy2.13924.

22.

A randomized controlled proof-of-concept trial of digoxin and furosemide in adults with cutaneous warts.

Rijsbergen M, Niemeyer-van der Kolk T, Hogendoorn G, Kouwenhoven S, Lemoine C, Klaassen ES, de Koning M, Beck S, Bouwes Bavinck JN, Feiss G, Burggraaf J, Rissmann R.

Br J Dermatol. 2019 May;180(5):1058-1068. doi: 10.1111/bjd.17583. Epub 2019 Mar 7.

PMID:
30580460
23.

The effect of repeated methotrexate injections on the quality of life of children with rheumatic diseases.

Jacobse J, Ten Voorde W, Rissmann R, Burggraaf J, Ten Cate R, Schrier L.

Eur J Pediatr. 2019 Jan;178(1):17-20. doi: 10.1007/s00431-018-3286-8. Epub 2018 Nov 17. Review.

24.

A Novel Somatostatin-Dopamine Chimera (BIM23B065) Reduced GH Secretion in a First-in-Human Clinical Trial.

de Boon WMI, van Esdonk MJ, Stuurman FE, Biermasz NR, Pons L, Paty I, Burggraaf J.

J Clin Endocrinol Metab. 2019 Mar 1;104(3):883-891. doi: 10.1210/jc.2018-01364.

PMID:
30371791
25.

Sugammadex hypersensitivity and underlying mechanisms: a randomised study of healthy non-anaesthetised volunteers.

de Kam PJ, Nolte H, Good S, Yunan M, Williams-Herman DE, Burggraaf J, Kluft C, Adkinson NF, Cullen C, Skov PS, Levy JH, van den Dobbelsteen DJ, van Heumen ELGM, van Meel FCM, Glassner D, Woo T, Min KC, Peeters PAM.

Br J Anaesth. 2018 Oct;121(4):758-767. doi: 10.1016/j.bja.2018.05.057. Epub 2018 Jul 13.

26.

Combination of a six microRNA expression profile with four clinicopathological factors for response prediction of systemic treatment in patients with advanced colorectal cancer.

Neerincx M, Poel D, Sie DLS, van Grieken NCT, Shankaraiah RC, van der Wolf-de Lijster FSW, van Waesberghe JTM, Burggraaf JD, Eijk PP, Verhoef C, Ylstra B, Meijer GA, van de Wiel MA, Buffart TE, Verheul HMW.

PLoS One. 2018 Aug 3;13(8):e0201809. doi: 10.1371/journal.pone.0201809. eCollection 2018.

27.

Assessment of Dermal Absorption of Aluminum from a Representative Antiperspirant Formulation Using a 26 Al Microtracer Approach.

de Ligt R, van Duijn E, Grossouw D, Bosgra S, Burggraaf J, Windhorst A, Peeters PAM, van der Luijt GA, Alexander-White C, Vaes WHJ.

Clin Transl Sci. 2018 Nov;11(6):573-581. doi: 10.1111/cts.12579. Epub 2018 Jul 27.

28.

Image-Guided Surgery in Patients with Pancreatic Cancer: First Results of a Clinical Trial Using SGM-101, a Novel Carcinoembryonic Antigen-Targeting, Near-Infrared Fluorescent Agent.

Hoogstins CES, Boogerd LSF, Sibinga Mulder BG, Mieog JSD, Swijnenburg RJ, van de Velde CJH, Farina Sarasqueta A, Bonsing BA, Framery B, Pèlegrin A, Gutowski M, Cailler F, Burggraaf J, Vahrmeijer AL.

Ann Surg Oncol. 2018 Oct;25(11):3350-3357. doi: 10.1245/s10434-018-6655-7. Epub 2018 Jul 26.

29.

Setting Standards for Reporting and Quantification in Fluorescence-Guided Surgery.

Hoogstins C, Burggraaf JJ, Koller M, Handgraaf H, Boogerd L, van Dam G, Vahrmeijer A, Burggraaf J.

Mol Imaging Biol. 2019 Feb;21(1):11-18. doi: 10.1007/s11307-018-1220-0.

PMID:
29845427
30.

Malleostapedotomy with the self-fixing and articulated titanium piston.

Burggraaf J, Mylanus EAM, Pennings RJE, Cremers C.

Eur Arch Otorhinolaryngol. 2018 Jul;275(7):1715-1722. doi: 10.1007/s00405-018-4999-z. Epub 2018 May 19.

31.

Comprehensive, Multimodal Characterization of an Imiquimod-Induced Human Skin Inflammation Model for Drug Development.

van der Kolk T, Assil S, Rijneveld R, Klaassen ES, Feiss G, Florencia E, Prens EP, Burggraaf J, Moerland M, Rissmann R, van Doorn MBA.

Clin Transl Sci. 2018 Nov;11(6):607-615. doi: 10.1111/cts.12563. Epub 2018 Jul 3.

32.

How are growth hormone and insulin-like growth factor-1 reported as markers for drug effectiveness in clinical acromegaly research? A comprehensive methodologic review.

van Esdonk MJ, van Zutphen EJM, Roelfsema F, Pereira AM, van der Graaf PH, Biermasz NR, Stevens J, Burggraaf J.

Pituitary. 2018 Jun;21(3):310-322. doi: 10.1007/s11102-018-0884-4. Review.

33.

Fosfomycin as a potential therapy for the treatment of systemic infections: a population pharmacokinetic model to simulate multiple dosing regimens.

Ortiz Zacarías NV, Dijkmans AC, Burggraaf J, Mouton JW, Wilms EB, van Nieuwkoop C, Touw DJ, Kamerling IMC, Stevens J.

Pharmacol Res Perspect. 2018 Feb;6(1). doi: 10.1002/prp2.378.

34.

Folate receptor-α targeted near-infrared fluorescence imaging in high-risk endometrial cancer patients: a tissue microarray and clinical feasibility study.

Boogerd LSF, Hoogstins CES, Gaarenstroom KN, de Kroon CD, Beltman JJ, Bosse T, Stelloo E, Vuyk J, Low PS, Burggraaf J, Vahrmeijer AL.

Oncotarget. 2017 Dec 11;9(1):791-801. doi: 10.18632/oncotarget.23155. eCollection 2018 Jan 2.

35.

Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study.

Boogerd LSF, Hoogstins CES, Schaap DP, Kusters M, Handgraaf HJM, van der Valk MJM, Hilling DE, Holman FA, Peeters KCMJ, Mieog JSD, van de Velde CJH, Farina-Sarasqueta A, van Lijnschoten I, Framery B, Pèlegrin A, Gutowski M, Nienhuijs SW, de Hingh IHJT, Nieuwenhuijzen GAP, Rutten HJT, Cailler F, Burggraaf J, Vahrmeijer AL.

Lancet Gastroenterol Hepatol. 2018 Mar;3(3):181-191. doi: 10.1016/S2468-1253(17)30395-3. Epub 2018 Jan 30.

PMID:
29361435
36.

Gender differences in clinical registration trials: is there a real problem?

Labots G, Jones A, de Visser SJ, Rissmann R, Burggraaf J.

Br J Clin Pharmacol. 2018 Apr;84(4):700-707. doi: 10.1111/bcp.13497. Epub 2018 Feb 12.

37.

Fosfomycin: Pharmacological, Clinical and Future Perspectives.

Dijkmans AC, Zacarías NVO, Burggraaf J, Mouton JW, Wilms EB, van Nieuwkoop C, Touw DJ, Stevens J, Kamerling IMC.

Antibiotics (Basel). 2017 Oct 31;6(4). pii: E24. doi: 10.3390/antibiotics6040024. Review.

38.

Characterization of immune cell, endothelial, and renal responses upon experimental human endotoxemia.

van Poelgeest EP, Dillingh MR, de Kam M, Malone KE, Kemper M, Stroes ESG, Burggraaf J, Moerland M.

J Pharmacol Toxicol Methods. 2018 Jan - Feb;89:39-46. doi: 10.1016/j.vascn.2017.10.004. Epub 2017 Oct 19.

PMID:
29056520
39.

Safety and dose-dependency of eptacog beta (activated) in a dose escalation study of non-bleeding congenital haemophilia A or B patients, with or without inhibitors.

Ducore J, Lawrence JB, Simpson M, Boggio L, Bellon A, Burggraaf J, Stevens J, Moerland M, Frieling J, Reijers J, Wang M.

Haemophilia. 2017 Nov;23(6):844-851. doi: 10.1111/hae.13357. Epub 2017 Oct 5.

PMID:
28984010
40.

Developing and validating the Cutaneous WARTS (CWARTS) diagnostic tool: a novel clinical assessment and classification system for cutaneous warts.

Hogendoorn GK, Bruggink SC, Hermans KE, Kouwenhoven STP, Quint KD, Wolterbeek R, Eekhof JAH, de Koning MNC, Rissmann R, Burggraaf J, Bouwes Bavinck JN.

Br J Dermatol. 2018 Feb;178(2):527-534. doi: 10.1111/bjd.15999. Epub 2017 Dec 18.

PMID:
28949011
41.

Retinal microcirculation imaging in sickle cell disease patients.

Birkhoff W, de Vries J, Dent G, Verma A, Kerkhoffs JL, van Meurs AHF, de Kam M, Moerland M, Burggraaf J.

Microvasc Res. 2018 Mar;116:1-5. doi: 10.1016/j.mvr.2017.09.001. Epub 2017 Sep 22.

PMID:
28943261
42.

In Search for Optimal Targets for Intraoperative Fluorescence Imaging of Peritoneal Metastasis From Colorectal Cancer.

Hoogstins CE, Weixler B, Boogerd LS, Hoppener DJ, Prevoo HA, Sier CF, Burger JW, Verhoef C, Bhairosingh S, Farina Sarasqueta A, Burggraaf J, Vahrmeijer AL.

Biomark Cancer. 2017 Aug 28;9:1179299X17728254. doi: 10.1177/1179299X17728254. eCollection 2017.

43.

Multi-parameter comparison of a standardized mixed meal tolerance test in healthy and type 2 diabetic subjects: the PhenFlex challenge.

Wopereis S, Stroeve JHM, Stafleu A, Bakker GCM, Burggraaf J, van Erk MJ, Pellis L, Boessen R, Kardinaal AAF, van Ommen B.

Genes Nutr. 2017 Aug 29;12:21. doi: 10.1186/s12263-017-0570-6. eCollection 2017.

44.

MDCO-216 Does Not Induce Adverse Immunostimulation, in Contrast to Its Predecessor ETC-216.

Reijers JAA, Kallend DG, Malone KE, Jukema JW, Wijngaard PLJ, Burggraaf J, Moerland M.

Cardiovasc Drugs Ther. 2017 Aug;31(4):381-389. doi: 10.1007/s10557-017-6746-x.

45.

Topical ionic contra-viral therapy comprised of digoxin and furosemide as a potential novel treatment approach for common warts.

van der Kolk T, Dillingh MR, Rijneveld R, Klaassen ES, de Koning MNC, Kouwenhoven STP, Genders RE, Bouwes Bavinck JN, Feiss G, Rissmann R, Burggraaf J.

J Eur Acad Dermatol Venereol. 2017 Dec;31(12):2088-2090. doi: 10.1111/jdv.14527. Epub 2017 Sep 6.

46.

Potential Influence of Endothelial Adsorption on the Delayed Time to Maximum Concentration of Biopharmaceuticals.

Reijers JAA, Dane MJC, van Zonneveld AJ, Burggraaf J, Moerland M.

Eur J Drug Metab Pharmacokinet. 2018 Feb;43(1):103-113. doi: 10.1007/s13318-017-0430-1.

47.

Effects of erythropoietin on cycling performance of well trained cyclists: a double-blind, randomised, placebo-controlled trial.

Heuberger JAAC, Rotmans JI, Gal P, Stuurman FE, van 't Westende J, Post TE, Daniels JMA, Moerland M, van Veldhoven PLJ, de Kam ML, Ram H, de Hon O, Posthuma JJ, Burggraaf J, Cohen AF.

Lancet Haematol. 2017 Aug;4(8):e374-e386. doi: 10.1016/S2352-3026(17)30105-9. Epub 2017 Jun 29.

PMID:
28669689
48.

Morphological characteristics and human papillomavirus genotype predict the treatment response in cutaneous warts.

Hogendoorn GK, Bruggink SC, de Koning MNC, Eekhof JAH, Hermans KE, Rissmann R, Burggraaf J, Wolterbeek R, Quint KD, Kouwenhoven STP, Bouwes Bavinck JN.

Br J Dermatol. 2018 Jan;178(1):253-260. doi: 10.1111/bjd.15758. Epub 2017 Dec 14.

PMID:
28646591
49.

[Fosfomycin, an old antibiotic with new possibilities].

Dijkmans AC, Kuiper SG, Burggraaf J, Mouton JW, Wilms EB, Touw DJ, Stevens J, van Nieuwkoop C, Kamerling IMC.

Ned Tijdschr Geneeskd. 2017;161:D973. Dutch.

PMID:
28612692
50.

Novel SGLT2 inhibitor: first-in-man studies of antisense compound is associated with unexpected renal effects.

van Meer L, van Dongen M, Moerland M, de Kam M, Cohen A, Burggraaf J.

Pharmacol Res Perspect. 2017 Jan 17;5(1):e00292. doi: 10.1002/prp2.292. eCollection 2017 Feb.

Supplemental Content

Loading ...
Support Center